Salivary Gland and Other Head and Neck Structures

  • Conrad Schuerch


This chapter is designed as an easy reference for the practicing pathologist aiming to solve diagnostic problems in head and neck pathology by immunohistochemistry (IHC). It is a collection of 38 practical tables including tables for commonly used antibodies, IHC reactions in normal salivary gland, IHC reactions in common salivary gland and head and neck tumors, and IHC reactions to resolve differential diagnostic challenges. Also included are practical footnotes and photographic illustrations.


Head and neck pathology Immunohisto­chemistry Salivary gland tumors Antibodies 


  1. 1.
    Foschini MP, Marucci G, Eusebi V. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation. Virchows Arch. 2002;440(5):536–42.PubMedCrossRefGoogle Scholar
  2. 2.
    Azevedo RS, de Almeida OP, Kowalski LP, Pires FR. Comparative cytokeratin expression in the different cell types of salivary gland mucoepidermoid carcinoma. Head Neck Pathol. 2008;2:257.PubMedCrossRefGoogle Scholar
  3. 3.
    Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci U S A. 1993;90(3):999–1003.PubMedCrossRefGoogle Scholar
  4. 4.
    Dabbs DJ. Diagnostic immunohistochemistry. 3rd ed. Philadelphia, PA: Churchill Livingstone Elsevier; 2010. Accessed 14 Mar 2010.Google Scholar
  5. 5.
    Kennedy M, Jordan R, Berean K, et al. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J Clin Pathol. 2004;57:932.PubMedCrossRefGoogle Scholar
  6. 6.
    Regauer S, Beham A, Mannweiler S. CK7 expression in carcinomas of the Waldeyer’s ring area. Hum Pathol. 2000;31:1096.PubMedCrossRefGoogle Scholar
  7. 7.
    Xia W, Yiu-Kueng L, Hu M, et al. High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene. 2000;19(20):2398.PubMedCrossRefGoogle Scholar
  8. 8.
    Iwafuchi H, Mori N, Takahashi T, Yatabe Y. Phenotypic composition of salivary gland tumors: an application of principal [corrected] component analysis to tissue microarray data. Mod Pathol. 2004;17(7):803–10.PubMedCrossRefGoogle Scholar
  9. 9.
    Mino M, Pilch BZ, Faquin WC. Expression of KIT (CD117) in neoplasms of the head and neck: an ancillary marker for adenoid cystic carcinoma. Mod Pathol. 2003;16(12):1224.PubMedCrossRefGoogle Scholar
  10. 10.
    Rossi S, Orvieto E, Furlanetto A, Laurino L, Ninfo V, Dei Tos AP. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol. 2004;17(5):547–52.PubMedCrossRefGoogle Scholar
  11. 11.
    Winter MJ, Nagtegaal ID, van Krieken JH, Litvinov SV. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol. 2003;163(6):2139–48.PubMedCrossRefGoogle Scholar
  12. 12.
    Viacava P, Naccarato AG, Bevilacqua G. Spectrum of GCDFP-15 expression in human fetal and adult normal tissues. Virchows Arch. 1998;432(3):255–60.PubMedCrossRefGoogle Scholar
  13. 13.
    Watanabe K, Tajino T, Sekiguchi M, Suzuki T. h-Caldesmon as a specific marker for smooth muscle tumors. Comparison with other smooth muscle markers in bone tumors. Am J Clin Pathol. 2000;113(5):663–8.PubMedGoogle Scholar
  14. 14.
    Alves SM, Cardoso SV, de Fatima Bernardes V, et al. Metallothionein immunostaining in adenoid cystic carcinomas of the salivary glands. Oral Oncol. 2007;43(3):252.PubMedCrossRefGoogle Scholar
  15. 15.
    Dutsch-Wicherek M, Popiela TJ, Klimek M, et al. Metallothionein stroma reaction in tumour adjacent healthy tissue in head and neck squamous cell carcinoma and breat adenocarcinoma. Neuro Endocrinol Lett. 2005;26(5):567.PubMedGoogle Scholar
  16. 16.
    Cherian MG, Jayasurya A, Bay BH. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res. 2003;533(1–2):201–9.PubMedGoogle Scholar
  17. 17.
    Sundelin K, Jadner M, Norberg-Spaak L, Davidsson A, Hellquist HB. Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue. Eur J Cancer. 1997;33(11):1860–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Gao Y, Han Z, Liu X. Megallothionein expression and its significance in salivary gland tumors. Zhonghua Kou Qiang Yi Xue Za Zhi. 1997;32(5):282.PubMedGoogle Scholar
  19. 19.
    Marioni G, Staffieri A, Bertolin A, et al. Laryngeal carcinoma lymph node metastasis and disease-free survival correlate with MASPIN nuclear expression but not with EGFR expression: a series of 108 cases. Eur Arch Otorhinolaryngol. 2010;267(7):1103–10.PubMedCrossRefGoogle Scholar
  20. 20.
    Schwarz S, Ettl T, Kleinsasser N, Hartmann A, Reichert TE, Driemel O. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors. Oral Oncol. 2008;44(6):563–70.PubMedCrossRefGoogle Scholar
  21. 21.
    Meer S, Altini M. CK7+/CK20− immunoexpression profile is typical of salivary gland neoplasia. Histopathology. 2007;51(1):26.PubMedCrossRefGoogle Scholar
  22. 22.
    Nakatsuka S, Oji Y, Horiuchi T, et al. Immunohistochemical detection of WT1 protein in a variety of cancer cells. Mod Pathol. 2006;19(6):804–14.PubMedGoogle Scholar
  23. 23.
    Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology. 2002;40(5):403–39.PubMedCrossRefGoogle Scholar
  24. 24.
    Wu HH, Zafar S, Huan Y, Yee H, Chiriboga L, Wang BY. Fascin over expression is associated with dysplastic changes in sinonasal inverted papillomas: a study of 47 cases. Head Neck Pathol. 2009;3:212–6.PubMedCrossRefGoogle Scholar
  25. 25.
    Mukunyadzi P, Ai L, Portilla D, Barnes EL, Fan CY. Expression of peroxisome proliferator-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases. Mod Pathol. 2003;16(12):1218–23.PubMedCrossRefGoogle Scholar
  26. 26.
    Barnes L, Rao U, Contis L, Krause J, Schwartz A, Scalamogna P. Salivary duct carcinoma. Part II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D, and c-erbB-2 protein. Oral Surg Oral Med Oral Pathol. 1994;78(1):74–80.PubMedCrossRefGoogle Scholar
  27. 27.
    Pires FR, da Cruz Perez DE, de Almeida OP, Kowalski LP. Estrogen receptor expression in salivary gland mucoepidermoid carcinoma and adenoid cystic carcinoma. Pathol Oncol Res. 2004;10(3):166–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Huang JW, Ming Z, Shrestha P, et al. Immunohistochemical evaluation of the Ca(2+)-binding S-100 proteins S-100A1, S-100A2, S-100A4, S-100A6 and S-100B in salivary gland tumors. J Oral Pathol Med. 1996;25(10):547–55.PubMedCrossRefGoogle Scholar
  29. 29.
    Savera AT, Gown AM, Zarbo RJ. Immunolocalization of three novel smooth muscle-specific proteins in salivary gland pleomorphic adenoma: assessment of the morphogenetic role of myoepithelium. Mod Pathol. 1997;10(11):1093–100.PubMedGoogle Scholar
  30. 30.
    Seethala RR, LiVolsi VA, Zhang PJ, Pasha TL, Baloch ZW. Comparison of P63 and P73 expression in benign and malignant salivary gland lesions. Head Neck. 2005;27:696.PubMedCrossRefGoogle Scholar
  31. 31.
    Nikitakis NG, Tosios KI, Papanikolaou VS, Rivera H, Papanicolaou SI, Ioffe OB. Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors. Mod Pathol. 2004;17(4):407–15.PubMedCrossRefGoogle Scholar
  32. 32.
    Azumi N, Battifora H. The cellular composition of adenoid cystic carcinoma. An immunohistochemical study. Cancer. 1987;60(7):1589–98.PubMedCrossRefGoogle Scholar
  33. 33.
    Weber A, Langhanki L, Schutz A, et al. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virchows Arch. 2002;441(5):428–36.PubMedCrossRefGoogle Scholar
  34. 34.
    Darling MR, Schneider JW, Phillips VM. Polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma: a review and comparison of immunohistochemical markers. Oral Oncol. 2002;38(7):641–5.PubMedCrossRefGoogle Scholar
  35. 35.
    de Araujo VC, de Sousa SO. Expression of different keratins in salivary gland tumours. Eur J Cancer B Oral Oncol. 1996;32B(1):14–8.PubMedCrossRefGoogle Scholar
  36. 36.
    Sobral AP, Loducca SV, Kowalski LP, et al. Immunohistochemical distinction of high-grade mucoepidermoid carcinoma and epidermoid carcinoma of the parotid region. Oral Oncol. 2002;38(5):437–40.PubMedCrossRefGoogle Scholar
  37. 37.
    Su L, Morgan PR, Harrison DL, Waseem A, Lane EB. Expression of keratin mRNAs and proteins in normal salivary epithelia and pleomorphic adenomas. J Pathol. 1993;171(3):173–81.PubMedCrossRefGoogle Scholar
  38. 38.
    Zarbo RJ. Salivary gland neoplasia: a review for the practicing pathologist. Mod Pathol. 2002;15(3):298–323.PubMedCrossRefGoogle Scholar
  39. 39.
    Foschini MP, Scarpellini F, Gown AM, Eusebi V. Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol. 2000;8(1):29.PubMedCrossRefGoogle Scholar
  40. 40.
    Ogawa Y, Toyosawa S, Ishida T, Ijuhin N. Keratin 14 immunoreactive cells in pleomorphic adenomas and adenoid cystic carcinomas of salivary glands. Virchows Arch. 2000;437(1):58–68.PubMedCrossRefGoogle Scholar
  41. 41.
    Tsukitani K, Nakai M, Tatemoto Y, Hikosaka N, Mori M. Histochemical studies of obstructive adenitis in human submandibular salivary glands. I. Immunohistochemical demonstration of lactoferrin, lysozyme and carcinoembryonic antigen. J Oral Pathol. 1985;14:631.PubMedCrossRefGoogle Scholar
  42. 42.
    Epivatianos A, Iordanides S, Zaraboukas T, Antoniades D. Adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma of minor salivary glands: a comparative immunohistochemical study using the epithelial membrane and carcinoembryonic antibodies. Oral Dis. 2005;11(3):175–80.PubMedCrossRefGoogle Scholar
  43. 43.
    Bilal H, Handra-Luca A, Bertrand JC, Fouret PJ. P63 is expressed in basal and myoepithelial cells of human normal and tumor salivary gland tissues. J Histochem Cytochem. 2003;51(2):133–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Langman G, Andrews CL, Weissferdt A. WT-1 Expression in salivary gland pleomorphic adenomas: a reliable marker of neoplastic myoepithelium. 2010. Modern pathol. 2011 Feb, 24(2):168–74.Google Scholar
  45. 45.
    Gonzalez-Alva P, Tanaka A, Oku Y, et al. Enhanced expression of podoplanin in ameloblastomas. J Oral Pathol Med. 2010;39(1):103.PubMedCrossRefGoogle Scholar
  46. 46.
    Alos L, Lujan B, Castillo M, et al. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands. Am J Surg Pathol. 2005;29(6):806–13.PubMedCrossRefGoogle Scholar
  47. 47.
    Handra-Luca A, Lamas G, Bertrand JC, Fouret P. MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol. 2005;29(7):881–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Shi J, Huang Y, Liu H, Lin F. The von Hipple–Lindau gene product (Pvhl) is a useful marker in differentiating salivary acinar cell carcinoma from oncocytoma. Mod. Pathol. 2009;Suppl 22:96A.Google Scholar
  49. 49.
    Ogawa Y. Immunocytochemistry of myoepithelial cells in the salivary glands. Prog Histochem Cytochem. 2003;38(4):343–426.PubMedCrossRefGoogle Scholar
  50. 50.
    Itoiz ME, Lanfranchi HE, Cabrini RL, Dominguez FV. Immunocytochemical detection of carcinoembryonic antigen in salivary gland tumors. Int J Oral Surg. 1983;12(5):340–3.PubMedCrossRefGoogle Scholar
  51. 51.
    Nakazato Y, Ishida Y, Takahashi K, Suzuki K. Immunohistochemical distribution of S-100 protein and glial fibrillary acidic protein in normal and neoplastic salivary glands. Virchows Arch A Pathol Anat Histopathol. 1985;405(3):299–310.PubMedCrossRefGoogle Scholar
  52. 52.
    DeRoche TC, Hoschar AP, Hunt JL. Immunohistochemical evaluation of androgen receptor, HER-2/neu, and p53 in benign pleomorphic adenomas. Arch Pathol Lab Med. 2008;132(12):1907–11.PubMedGoogle Scholar
  53. 53.
    Edwards PC, Bhuiya T, Kelsch RD. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(5):613–9.PubMedCrossRefGoogle Scholar
  54. 54.
    Zarbo RJ, Prasad AR, Regezi JA, Gown AM, Savera AT. Salivary gland basal cell and canalicular adenomas: immunohistochemical demonstration of myoepithelial cell participation and morphogenetic considerations. Arch Pathol Lab Med. 2000;124(3):401–5.PubMedGoogle Scholar
  55. 55.
    de Araujo VC, de Sousa SO, Carvalho YR, de Araujo NS. Application of immunohistochemistry to the diagnosis of salivary gland tumors. Appl Immunohistochem Mol Morphol. 2000;8(3):195–202.PubMedCrossRefGoogle Scholar
  56. 56.
    Prasad AR, Savera AT, Gown AM, Zarbo RJ. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma. Arch Pathol Lab Med. 1999;123(9):801–6.PubMedGoogle Scholar
  57. 57.
    Alos L, Cardesa A, Bombi JA, Mallofre C, Cuchi A, Traserra J. Myoepithelial tumors of salivary glands: a clinicopathologic, immunohistochemical, ultrastructural, and flow-cytometric study. Semin Diagn Pathol. 1996;13(2):138–47.PubMedGoogle Scholar
  58. 58.
    Takahashi H, Tsuda N, Tezuka F, Okabe H. Immunohistochemical localization of carcinoembryonic antigen in carcinoma in pleomorphic adenoma of salivary gland: use in the diagnosis of benign and malignant lesions. Tohoku J Exp Med. 1986;149(3):329–40.PubMedCrossRefGoogle Scholar
  59. 59.
    Ferreiro JA. Immunohistochemistry of basal cell adenoma of the major salivary glands. Histopathology. 1994;24(6):539–42.PubMedCrossRefGoogle Scholar
  60. 60.
    Pereira MC, Pereira AA, Hanemann JA. Immunohistochemical profile of canalicular adenoma of the upper lip: a case report. Med Oral Patol Oral Cir Bucal. 2007;12(1):E1–3.PubMedGoogle Scholar
  61. 61.
    Yuri T, Mitsuyoshi H, Yoshiaki N, Hiromi K, Takeshi O, Chotatsu T. Morphology of myoepithelial cells seen in pleomorphic ­adenoma of the salivary gland. J Japan Soc Clin Cytol. 1999;38(5):403.CrossRefGoogle Scholar
  62. 62.
    Cavalcante RB, Lopes FF, Ferreira AS, Freitas Rde A, de Souza LB. Immunohistochemical expression of vimentin, calponin and HHF-35 in salivary gland tumors. Braz Dent J. 2007;18(3):192–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Korsrud FR, Brandtzaeg P. Immunofluorescence study of secretory epithelial markers in pleomorphic adenomas. Virchows Arch A Pathol Anat Histopathol. 1984;403(3):291–300.PubMedCrossRefGoogle Scholar
  64. 64.
    Dardick I, Claude A, Parks WR, et al. Warthin’s tumor: an ultrastructural and immunohistochemical study of basilar epithelium. Ultrastruct Pathol. 1988;12(4):419–32.PubMedCrossRefGoogle Scholar
  65. 65.
    Segami N, Fukuda M, Manabe T. Immunohistological study of the epithelial components of Warthin’s tumor. Int J Oral Maxillofac Surg. 1989;18(3):133–7.PubMedCrossRefGoogle Scholar
  66. 66.
    Schwerer MJ, Kraft K, Baczako K, Maier H. Cytokeratin expression and epithelial differentiation in Warthin’s tumour and its metaplastic (infarcted) variant. Histopathology. 2001;39(4):347–52.PubMedCrossRefGoogle Scholar
  67. 67.
    Zhou CX, Gao Y. Oncocytoma of the salivary glands: a clinicopathologic and immunohistochemical study. Oral Oncol. 2009;45(12):e232.PubMedCrossRefGoogle Scholar
  68. 68.
    McHugh JB, Hoschar AP, Dvorakova M, Parwani AV, Barnes EL, Seethala RR. p63 Immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma. Head Neck Pathol. 2007;1(2):123.PubMedCrossRefGoogle Scholar
  69. 69.
    Weiler C, Reu S, Zengel P, Kirchner T, Ihrler S. Obligate basal cell component in salivary oncocytoma facilitates distinction from acinic cell carcinoma. Pathol Res Pract. 2009;205(12):838–42.PubMedCrossRefGoogle Scholar
  70. 70.
    Thompson LD, Wenig BM, Ellis GL. Oncocytomas of the submandibular gland. A series of 22 cases and a review of the literature. Cancer. 1996;78(11):2281–7.PubMedCrossRefGoogle Scholar
  71. 71.
    Lee JH, Lee JH, Kim A, Kim I, Chae YS. Unique expression of MUC3, MUC5AC and cytokeratins in salivary gland carcinomas. Pathol Int. 2005;55(7):386–90.PubMedCrossRefGoogle Scholar
  72. 72.
    Loyola A, de Sousa SO, Araujo NS, Araujo VC. Study of minor salivary gland mucoepidermoid carcinoma differentiation based on immunohistochemical expression of cytokeratins, vimentin and muscle-specific actin. Oral Oncol. 1998;34(2):112.PubMedCrossRefGoogle Scholar
  73. 73.
    Araujo V, Sousa S, Jaeger M, et al. Characterization of the cellular component of polymorphous low-grade adenocarcinoma by immunohistochemistry and electron microscopy. Oral Oncol. 1999;35(2):164–72.PubMedCrossRefGoogle Scholar
  74. 74.
    Klijanienko J, el-Naggar A, Ponzio-Prion A, Marandas P, Micheau C, Caillaud JM. Basaloid squamous carcinoma of the head and neck. Immunohistochemical comparison with adenoid cystic carcinoma and squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1993;119(8):887–90.PubMedCrossRefGoogle Scholar
  75. 75.
    Furuse C, Cury PR, de Araujo NS, de Araujo VC. Application of two different clones of vimentin to the diagnosis of salivary gland tumors. Appl Immunohistochem Mol Morphol. 2006;14(2):217–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Nagao T, Gaffey TA, Serizawa H, et al. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol. 2003;16(12):1265–72.PubMedCrossRefGoogle Scholar
  77. 77.
    Watanabe Y, Wato M. Expression of p16 and p73 in adenoid cystic carcinoma of the salivary gland. J Osaka Dental Univ. 2007;41(1):1.Google Scholar
  78. 78.
    Skalova A, Vanecek T, Sima R, et al. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity. Am J Surg Pathol. 2010;34(5):599–608.PubMedGoogle Scholar
  79. 79.
    Ihrler S, Blasenbreu-Vogt S, Sendelhofert A, Lang S, Zietz C, Lohrs U. Differential diagnosis of salivary acinic cell carcinoma and adenocarcinoma (NOS). A comparison of (immuno-)histochemical markers. Pathol Res Pract. 2002;198(12):777–83.PubMedGoogle Scholar
  80. 80.
    Crivelini MM, de Sousa SO, de Araujo VC. Immunohistochemical study of acinic cell carcinoma of minor salivary gland. Oral Oncol. 1997;33(3):204–8.PubMedCrossRefGoogle Scholar
  81. 81.
    Warner TF, Seo IS, Azen EA, Hafez GR, Zarling TA. Immunocytochemistry of acinic cell carcinomas and mixed tumors of salivary glands. Cancer. 1985;56(9):2221–7.PubMedCrossRefGoogle Scholar
  82. 82.
    Emanuel P, Wang B, Wu M, Burstein DE. p63 Immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol. 2005;18:645.PubMedCrossRefGoogle Scholar
  83. 83.
    Skalova A, Starek I, Vanecek T, et al. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry. Histopathology. 2003;42(4):348–56.PubMedCrossRefGoogle Scholar
  84. 84.
    Moriki T, Ueta S, Takahashi T, Mitani M, Ichien M. Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis. Cancer. 2001;93(5):344–50.PubMedCrossRefGoogle Scholar
  85. 85.
    Johnson CJ, Barry MB, Vasef MA, Deyoung BR. Her-2/neu expression in salivary duct carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Appl Immunohistochem Mol Morphol. 2008;16(1):54–8.PubMedGoogle Scholar
  86. 86.
    Etges A, Pinto Jr DS, Kowalski LP, Soares FA, Araujo VC. Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumour. J Clin Pathol. 2003;56(12):914–8.PubMedCrossRefGoogle Scholar
  87. 87.
    Kawahara A, Harada H, Akiba J, Kage M. Salivary duct carcinoma cytologically diagnosed distinctly from salivary gland carcinomas with squamous differentiation. Diagn Cytopathol. 2008;36(7):485–93.PubMedCrossRefGoogle Scholar
  88. 88.
    Brandwein-Gensler M, Hille J, Wang BY, et al. Low-grade salivary duct carcinoma: description of 16 cases. Am J Surg Pathol. 2004;28(8):1040–4.PubMedCrossRefGoogle Scholar
  89. 89.
    Sygut D, Bien S, Ziolkowska M, Sporny S. Immunohistochemical expression of androgen receptor in salivary gland cancers. Polish J Pathol. 2008;59(4):205–10.Google Scholar
  90. 90.
    Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol. 2003;119(6):801–6.PubMedCrossRefGoogle Scholar
  91. 91.
    Barnes L, Eveson JW, Reichart P, Sidransky D. WHO classification of tumours pathology & genetics head and neck tumours. Lyon: International Agency for Research on Cancer; 2005. p. 430. Accessed 19 Apr 2010.Google Scholar
  92. 92.
    Farrell T, Chang YL. Basal cell adenocarcinoma of minor salivary gland. Arch Pathol Lab Med. 2007;131(10):1602.PubMedGoogle Scholar
  93. 93.
    Quddus MR, Henley JD, Affify AM, et al. Basal cell adenocarcinoma of the salivary gland. An ultrastructural and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;87:485.PubMedCrossRefGoogle Scholar
  94. 94.
    Parashar P, Baron E, Papadimitriou JC, Ord RA, Nikitakis NG, University of Maryland. Basal cell adenocarcinoma of the oral minor salivary glands: review of the literature and presentation of two cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:77.PubMedCrossRefGoogle Scholar
  95. 95.
    Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol. 2007;31(1):44–57.PubMedCrossRefGoogle Scholar
  96. 96.
    Dardick I, Thomas MJ, van Nostrand AW. Myoepithelioma – new concepts of histology and classification: a light and electron microscopic study. Ultrastruct Pathol. 1989;13(2–3):187–224.PubMedCrossRefGoogle Scholar
  97. 97.
    Ramraje S, Bharambe B, Zode R. Epithelial myoepithelial carcinoma of the submandibular salivary gland. Bombay Hosp J. 2010;52(1):141.Google Scholar
  98. 98.
    Nagao T, Sugano I, Ishida Y, et al. Salivary gland malignant myoepithelioma: a clinicopathologic and immunohistochemical study of ten cases. Cancer. 1998;83(7):1292–9.PubMedCrossRefGoogle Scholar
  99. 99.
    Di Palma S, Guzzo M. Malignant myoepithelioma of salivary glands: clinicopathological features of ten cases. Virchows Arch A Pathol Anat Histopathol. 1993;423(5):389–96.PubMedCrossRefGoogle Scholar
  100. 100.
    Hornick JL, Fletcher CD. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters. Am J Surg Pathol. 2003;27(9):1183.PubMedCrossRefGoogle Scholar
  101. 101.
    Savera AT, Sloman A, Huvos AG, Klimstra DS. Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients. Am J Surg Pathol. 2000;24(6):761–74.PubMedCrossRefGoogle Scholar
  102. 102.
    Jones H, Moshtael F, Simpson RH. Immunoreactivity of alpha smooth muscle actin in salivary gland tumours: a comparison with S100 protein. J Clin Pathol. 1992;45(10):938–40.PubMedCrossRefGoogle Scholar
  103. 103.
    Takahashi H, Tsuda N, Tezuka F, Okabe H. An immunoperoxidase investigation of S-100 protein in the epithelial component of Warthin’s tumor. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1986;62(1):57.Google Scholar
  104. 104.
    Solar AA, Schmidt BL, Jordan RC. Hyalinizing clear cell carcinoma: case series and comprehensive review of the literature. Cancer. 2009;115(1):75–83.PubMedCrossRefGoogle Scholar
  105. 105.
    O’Sullivan-Meja ED, Massey HD, Faquin WC, Powes CN. Hylanizing clear cell carcinoma: report of eight cases and a review of literature. Head Neck Pathol. 2009;3:179.CrossRefGoogle Scholar
  106. 106.
    Wang B, Brandwein M, Gordon R, Robinson R, Urken M, Zarbo RJ. Primary salivary clear cell tumors – a diagnostic approach: a clinicopathologic and immunohistochemical study of 20 patients with clear cell carcinoma, clear cell myoepithelial carcinoma, and epithelial–myoepithelial carcinoma. Arch Pathol Lab Med. 2002;126:676.PubMedGoogle Scholar
  107. 107.
    Vargas H, Sudilovsky D, Kaplan M, Regezi J, Weidner N. Mixed tumor, polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma of the salivary gland: pathogenic implications and differential diagnosis by Ki-67 (MIB1), BCL2, and S-100 immunohistochemistry. Appl Immunohistochem. 1997;5(1):8.CrossRefGoogle Scholar
  108. 108.
    Beltran D, Faquin WC, Gallagher G, August M. Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma. J Oral Maxillofac Surg. 2006;64(3):415–23.PubMedCrossRefGoogle Scholar
  109. 109.
    Prasad ML, Barbacioru CC, Rawal YB, Husein O, Wen P. Hierarchical cluster analysis of myoepithelial/basal cell markers in adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma. Mod Pathol. 2008;21(2):105–14.PubMedGoogle Scholar
  110. 110.
    Shibata R, Martiniuk F, Qian Y, et al. Immunohistochemical expression of c-kit (CD117) in mucosal melanomas of the head and neck. Lab Investig. 2010;90(11):280A.Google Scholar
  111. 111.
    Araujo VC, Loducca SV, Sousa SO, Williams DM, Araujo NS. The cribriform features of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma: cytokeratin and integrin expression. Ann Diagn Pathol. 2001;5(6):330–4.PubMedCrossRefGoogle Scholar
  112. 112.
    Gnepp DR, Chen JC, Warren C. Polymorphous low-grade adenocarcinoma of minor salivary gland. An immunohistochemical and clinicopathologic study. Am J Surg Pathol. 1988;12(6):461–8.PubMedCrossRefGoogle Scholar
  113. 113.
    Kawahara A, Harada H, Yokoyama T, Kage M. p63 Expression of clear myoepithelial cells in epithelial–myoepithelial carcinoma of the salivary gland: a useful marker for naked myoepithelial cells in cytology. Cancer. 2005;105(4):240–5.PubMedCrossRefGoogle Scholar
  114. 114.
    Ellis GL. “Clear cell” oncocytoma of salivary gland. Hum Pathol. 1988;19(7):862–7.PubMedCrossRefGoogle Scholar
  115. 115.
    Lai G, Nemolato S, Lecca S, Parodo G, Medda C, Faa G. The role of immunohistochemistry in the diagnosis of hyalinizing clear cell carcinoma of the minor salivary gland: a case report. Eur J Histochem. 2008;52(4):251–4.PubMedGoogle Scholar
  116. 116.
    Pires FR, Azevedo RS, Guiseppe F, et al. Metastatic renal cell carcinoma to the oral cavity and clear cell mucoepidermoid carcinoma: comparative clinicopathologic and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;109(4):e22–7.Google Scholar
  117. 117.
    Lueck N, Robinson RA. High levels of expression of cytokeratin 5 are strongly correlated with poor survival in higher grades of mucoepidermoid carcinoma. J Clin Pathol. 2008;61(7):837.PubMedCrossRefGoogle Scholar
  118. 118.
    Zarbo RJ, Regezi JA, Batsakis JG. S-100 protein in salivary gland tumors: an immunohistochemical study of 129 cases. Head Neck Surg. 1986;8(4):268–75.PubMedCrossRefGoogle Scholar
  119. 119.
    Saqi A, Giorgadze TA, Eleazar J, Remotti F, Vazquez MF. Clear cell and eosinophilic oncocytomas of salivary gland: cytological variants or parallels? Diagn Cytopathol. 2007;35(3):158–63.PubMedCrossRefGoogle Scholar
  120. 120.
    Neves C, Soares A, Costa A, et al. CD10 (neutral endopeptidase) expression in myoepithelial cells of salivary neoplasms. Appl Immunohistochem Mol Morphol. 2010;18(2):172.CrossRefGoogle Scholar
  121. 121.
    Angiero F, Sozzi D, Seramondi R, Valente MG. Epithelial–myoepithelial carcinoma of the minor salivary glands: immunohistochemical and morphological features. Anticancer Res. 2009;29(11):4703–9.PubMedGoogle Scholar
  122. 122.
    Lin F, Wannian Y, Betten M, Bin T, Yang XJ. Expression of S-100 protein in renal cell neoplasms. Hum Pathol. 2006;37(4):462.PubMedCrossRefGoogle Scholar
  123. 123.
    Ozolek J, Bastacky S, Myers E, Hunt J. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma. Laryngoscope. 2005;115:1097.PubMedCrossRefGoogle Scholar
  124. 124.
    Skalova A, Michal M, Ryska A, et al. Oncocytic myoepithelioma and pleomorphic adenoma of the salivary glands. Virchows Arch. 1999;434(6):537–46.PubMedCrossRefGoogle Scholar
  125. 125.
    Liu H, Shi J, Liang K, Meschter S, Lin F. Loss of or reduced expression of the Von Hipple–Lindau gene product (pVHL) in malignant salivary epithelial neoplasms – with an implication of its role in tumorigenesis. Mod Pathol. 2008;21(Suppl):1089.Google Scholar
  126. 126.
    Gustafsson H, Virtanen I, Thornell LE. Expression of cytokeratins and vimentin in salivary gland carcinomas as revealed with monoclonal antibodies. Virchows Arch. 1988;412(6):515.CrossRefGoogle Scholar
  127. 127.
    Faquin WC, Powers CN. Salivary gland cytopathology, Essentials in cytopathology, vol. 5. US: Springer; 2008. p. 156. Accessed 19 May 2010.CrossRefGoogle Scholar
  128. 128.
    Tickoo SK, Amin MB, Linden MD, Lee MW, Zarbo RJ. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. Am J Surg Pathol. 1997;21(8):922–30.PubMedCrossRefGoogle Scholar
  129. 129.
    Weinreb I, Seethala RR, Perez-Ordonez B, Chetty R, Hoschar AP, Hunt JL. Oncocytic mucoepidermoid carcinoma: clinicopathologic description in a series of 12 cases. Am J Surg Pathol. 2009;33(3):409–16.PubMedCrossRefGoogle Scholar
  130. 130.
    Dale BA, Salonen J, Jones AH. New approaches and concepts in the study of differentiation of oral epithelia. Crit Rev Oral Biol Med. 1990;1(3):167–90.PubMedGoogle Scholar
  131. 131.
    Morgan P, Leigh I, Purkis P, et al. Site variations in keratin expression in human oral epithelia: an immunohistochemical study of individual keratins. Epithelia. 1987;1:31.Google Scholar
  132. 132.
    Ogden GR, Lane EB, Hopwood DV, Chisholm DM. Evidence for field change in oral cancer based on cytokeratin expression. Br J Cancer. 1993;67:1324.PubMedCrossRefGoogle Scholar
  133. 133.
    Fillies T, Jogschies M, Kleinheinz J, Brandt B, Joos U, Buerger H. Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma. Oncol Rep. 2007;18:639.PubMedGoogle Scholar
  134. 134.
    Fillies T, Werkmeister R, Packeisen J, et al. Cytokeratin 8/18 expression indicates a poor prognosis in squamous cell carcinomas of the oral cavity. BMC Cancer. 2006;6(10):1471.Google Scholar
  135. 135.
    Ram Prassad VV, Nirmala NR, Kotian MS. Immunohistochemical evaluation of expression of cytokeratin 19 in different histological grades of leukoplakia and oral squamous cell carcinoma. Indian J Dent Res. 2005;16(1):6.PubMedGoogle Scholar
  136. 136.
    Gillison M, Koch W, Capone R, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709.PubMedCrossRefGoogle Scholar
  137. 137.
    Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005;32 Suppl 1:S59.PubMedCrossRefGoogle Scholar
  138. 138.
    McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck. 1998;20(3):250.PubMedCrossRefGoogle Scholar
  139. 139.
    Chernock R, El-Mofty SK, Thorstad WL, Parvin CA, Lewis JS. HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol. 2009;3(3):186–94.PubMedCrossRefGoogle Scholar
  140. 140.
    Winters R, Naud S, Evans M, Trotman W, Kasznica P, Elhosseiny A. Ber-EP4, CK1, CK7 and CK14 are useful markers for basaloid squamous carcinoma: a study of 45 cases. Head Neck Pathol. 2008;2(4):265.PubMedCrossRefGoogle Scholar
  141. 141.
    van der Velden LA, Schaafsman HE, Manni JJ, Ramaekers FC, Kuijpers W. Expression of cytokeratin subtypes and vimentin in squamous cell carcinoma of the floor of the mouth and the mobile tongue. Otorhinolaryngol Nova. 2001;11:186.CrossRefGoogle Scholar
  142. 142.
    van der Velden LA, Schaafsma HE, Manni JJ, Ruiter DJ, Ramaekers FC, Kuijpers W. Cytokeratin and vimentin expression in normal epithelium and squamous cell carcinomas of the larynx. Eur Arch Otorhinolaryngol. 1997;254(8):376–83.PubMedCrossRefGoogle Scholar
  143. 143.
    Fregonesi PA, Teresa DB, Duarte RA, Neto CB, de Oliveira MR, Soares CP. p16(INK4A) immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem. 2003;51(10):1291–7.PubMedCrossRefGoogle Scholar
  144. 144.
    Singhi A, Westra W. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116(9):2166–73.PubMedGoogle Scholar
  145. 145.
    Leonardi E, Dalri P, Pusiol T, Valdagni R, Piscioli F. Spindle-cell squamous carcinoma of head and neck region: a clinicopathologic and immunohistochemical study of eight cases. ORL J Otorhinolaryngol Relat Spec. 1986;48(5):275–81.PubMedCrossRefGoogle Scholar
  146. 146.
    Barnes L. Surgical pathology of the head and neck, vol. 1. 2nd ed. New York, NY: Marcel Kekker Ag; 2001. p. 786.Google Scholar
  147. 147.
    Barnes L. Surgical pathology of the head and neck, vol. 2. 2nd ed. New York, NY: Marcel Dekker AG; 2001. p. 649.Google Scholar
  148. 148.
    Barnes L. Surgical pathology of the head and neck, vol. 3. 2nd ed. New York, NY: Marcel Dekker AG; 2001. p. 772.Google Scholar
  149. 149.
    Serrano MF, El-Mofty SK, Gnepp DR, Lewis Jr JS. Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck. Hum Pathol. 2008;39(4):591–8.PubMedCrossRefGoogle Scholar
  150. 150.
    Chapman-Fredricks J, Jorda M, Gomez-Fernandez C. A limited immunohistochemical panel helps differentiate small cell epithelial malignancies of the sinonasal cavity and nasopharynx. Applied Immunohistochem Mol Morphol. 2009;17(3):207.CrossRefGoogle Scholar
  151. 151.
    Banks ER, Frierson Jr HF, Mills SE, George E, Zarbo RJ, Swanson PE. Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol. 1992;16(10):939–46.PubMedCrossRefGoogle Scholar
  152. 152.
    Hutcheson JA, Vural E, Korourian S, Hanna E. Neural cell adhesion molecule expression in adenoid cystic carcinoma of the head and neck. Laryngoscope. 2009;110(6):946.CrossRefGoogle Scholar
  153. 153.
    Gandour-Edwards R, Kapadia SB, Barnes L, Donald PJ, Janecka IP. Neural cell adhesion molecule in adenoid cystic carcinoma invading the skull base. Otolaryngol Head Neck Surg. 1997;117(5):453–8.PubMedCrossRefGoogle Scholar
  154. 154.
    Morice WG, Ferreiro JA. Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated ­carcinoma by immunohistochemistry. Hum Pathol. 1998;29(6):609–12.PubMedCrossRefGoogle Scholar
  155. 155.
    Lee JS, Ko IJ, Jun SY, Kim JY. Basaloid squamous cell carcinoma in nasal cavity. Clin Exp Otorhinolaryngol. 2009;2(4):207.PubMedCrossRefGoogle Scholar
  156. 156.
    Franchi A, Moroni M, Massi D, Paglierani M, Santucci M. Sinonasal undifferentiated carcinoma, nasopharyngeal-type undifferentiated carcinoma, and keratinizing and nonkeratinizing squamous cell carcinoma express different cytokeratin patterns. Am J Surg Pathol. 2002;26(12):1597–604.PubMedCrossRefGoogle Scholar
  157. 157.
    El-Mofty SK, Patil S. Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:339.PubMedCrossRefGoogle Scholar
  158. 158.
    Friedrich RE, Bartel-Friedrich S, Lobeck H, Niedobitek G, Arps H. Epstein–Barr virus DNA and epithelial markers in nasopharyngeal carcinoma. Med Microbiol Immunol (Berl). 2003;192(3):141–4.CrossRefGoogle Scholar
  159. 159.
    Bar-Sela G, Kuten A, Ben-Eliezer S, Gov-Ari E, Ben-Izhak O. Expression of HER2 and C-KIT in nasopharyngeal carcinoma: implications for a new therapeutic approach. Mod Pathol. 2003;16(10):1035–40.PubMedCrossRefGoogle Scholar
  160. 160.
    Jeng YM, Sung MT, Fang CL, et al. Sinonasal undifferentiated carcinoma and nasopharyngeal-type undifferentiated carcinoma: two clinically, biologically, and histopathologically distinct entities. Am J Surg Pathol. 2002;26(3):371–6.PubMedCrossRefGoogle Scholar
  161. 161.
    Bellizzi AM, Bruzzi C, French CA, Stelow EB. The cytologic features of NUT midline carcinoma. Cancer Cytopathol. 2009;117(6):508–15.Google Scholar
  162. 162.
    French CA, Kutok JL, Faquin WC, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004;22(20):4135–9.PubMedCrossRefGoogle Scholar
  163. 163.
    Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33(7):984–91.PubMedCrossRefGoogle Scholar
  164. 164.
    Stelow EB, Bellizzi AM, Taneja K, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008;32(6):828–34.PubMedCrossRefGoogle Scholar
  165. 165.
    French CA. Molecular pathology of NUT midline carcinomas. J Clin Pathol. 2010;63(6):492–6.PubMedCrossRefGoogle Scholar
  166. 166.
    Russell-Jones R, Orchard G, Zelger B, Wilson-Jones E. Immunostaining for CD31 and CD34 in Kaposi sarcoma. J Clin Pathol. 1995;48:1011.PubMedCrossRefGoogle Scholar
  167. 167.
    Zhang YM, Bachmann S, Hemmer C, et al. Vascular origin of Kaposi’s sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor. Am J Pathol. 1994;144(1):51–9.PubMedGoogle Scholar
  168. 168.
    Manning T, Smoller BR, Horn TD, et al. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms. J Cutan Pathol. 2004;31(10):652–6.PubMedCrossRefGoogle Scholar
  169. 169.
    Chan JK, Suster S, Wenig BM, Tsang WY, Chan JB, Lau AL. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol. 1997;21(2):226–34.PubMedCrossRefGoogle Scholar
  170. 170.
    Nagao T, Gaffey TA, Olsen KD, Serizawa H, Lewis JE. Small cell carcinoma of the major salivary glands: clinicopathologic study with emphasis on cytokeratin 20 immunoreactivity and clinical outcome. Am J Surg Pathol. 2004;28(6):762.PubMedCrossRefGoogle Scholar
  171. 171.
    Woodruff JM, Senie RT. Atypical carcinoid tumor of the larynx. A critical review of the literature. ORL J Otorhinolaryngol Relat Spec. 1991;53(4):194–209.PubMedCrossRefGoogle Scholar
  172. 172.
    Ferlito A, Rinaldo A. Primary and secondary small cell neuroendocrine carcinoma of the larynx: a review. Head Neck. 2008;30(4):518–24.PubMedCrossRefGoogle Scholar
  173. 173.
    Hirsch MS, Faquin WC, Krane JF. Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid. Mod Pathol. 2004;17(6):631–6.PubMedCrossRefGoogle Scholar
  174. 174.
    Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv Anat Pathol. 2009;16(5):322–31.PubMedCrossRefGoogle Scholar
  175. 175.
    Thompson LD, Miettinen M, Wenig BM. Sinonasal-type hemangiopericytoma: a clinicopathologic and immunophenotypic analysis of 104 cases showing perivascular myoid differentiation. Am J Surg Pathol. 2003;27(6):737–49.PubMedCrossRefGoogle Scholar
  176. 176.
    McKinney CD, Mills SE, Franquemont DW. Sinonasal intestinal-type adenocarcinoma: immunohistochemical profile and comparison with colonic adenocarcinoma. Mod Pathol. 1995;8(4):421–6.PubMedGoogle Scholar
  177. 177.
    Jo VY, Mills SE, Cathro HP, Carlson DL, Stelow EB. Low-grade sinonasal adenocarcinomas: the association with and distinction from respiratory epithelial adenomatoid hamartomas and other glandular lesions. Am J Surg Pathol. 2009;33(3):401–8.PubMedCrossRefGoogle Scholar
  178. 178.
    Vega F, Chang CC, Medeiros LJ, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol. 2005;18(6):806–15.PubMedCrossRefGoogle Scholar
  179. 179.
    Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28(6):736–47.PubMedCrossRefGoogle Scholar
  180. 180.
    Taddesse-Heath L, Meloni-Ehrig A, Scheerle J, Kelly JC, Jaffe ES. Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features. Mod Pathol. 2010;23(7):991–9.PubMedCrossRefGoogle Scholar
  181. 181.
    Cerilli LA, Holst VA, Brandwein MS, Stoler MH, Mills SE. Sinonasal undifferentiated carcinoma: immunohistochemical profile and lack of EBV association. Am J Surg Pathol. 2001;25(2):156–63.PubMedCrossRefGoogle Scholar
  182. 182.
    Thompson S. Sinonasal carcinomas. 2006;12(1):40. [2 Apr 2010].Google Scholar
  183. 183.
    Iezzoni JC, Mills SE. “Undifferentiated” small round cell tumors of the sinonasal tract: differential diagnosis update. Am J Clin Pathol. 2005;124(Suppl):S110–21.PubMedGoogle Scholar
  184. 184.
    Hirano T. Immunohistochemical study of malignant melanoma. Acta Pathol Jpn. 1986;36(5):733–43.PubMedGoogle Scholar
  185. 185.
    Carbone A, Gloghini A, Rinaldo A, Devaney KO, Tubbs R, Ferlito A. True identity by immunohistochemistry and molecular morphology of undifferentiated malignancies of the head and neck. Head Neck. 2009;31(7):949–61.PubMedCrossRefGoogle Scholar
  186. 186.
    Ejaz A, Wenig BM. Sinonasal undifferentiated carcinoma: clinical and pathologic features and a discussion on classification, cellular differentiation, and differential diagnosis. Adv Anat Pathol. 2005;12(3):134–43.PubMedCrossRefGoogle Scholar
  187. 187.
    Cordes B, Williams MD, Tirado Y, et al. Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification. Hum Pathol. 2009;40(3):283–92.PubMedCrossRefGoogle Scholar
  188. 188.
    Sung CO, Ko YH, Park S, Kim K, Kim W. Immunoreactivity of CD99 in non-Hodgkin’s lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lyphoma. J Korean Med Sci. 2005;20(6):952.PubMedCrossRefGoogle Scholar
  189. 189.
    Finke NM, Lae ME, Lloyd RV, Gehani SK, Nascimento AG. Sinonasal desmoplastic small round cell tumor: a case report. Am J Surg Pathol. 2002;26(6):799–803.PubMedCrossRefGoogle Scholar
  190. 190.
    Hirakawa N, Naka T, Yamamoto I, Fukuda T, Tsuneyoshi M. Overexpression of bcl-2 protein in synovial sarcoma: a comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization. Hum Pathol. 1996;27(10):1060–5.PubMedCrossRefGoogle Scholar
  191. 191.
    Kim JW, Kong IG, Lee CH, et al. Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival. Otolaryngol Head Neck Surg. 2008;139(5):708–12.PubMedCrossRefGoogle Scholar
  192. 192.
    Olsen SH, Thomas DG, Lucas DR. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Mod Pathol. 2006;19:659.PubMedCrossRefGoogle Scholar
  193. 193.
    Sebire NJ, Gibson S, Rampling D, Williams S, Malone M, Ramsay AD. Immunohistochemical findings in embryonal small round cell tumors with molecular diagnostic confirmation. Appl Immunohistochem Mol Morphol. 2005;13(1):1–5.PubMedCrossRefGoogle Scholar
  194. 194.
    Liu Q, Ohshima K, Sumie A, Suzushima H, Iwasaki H, Kikuchi M. Nasal CD56 positive small round cell tumors. Differential diagnosis of hematological, neurogenic, and myogenic neoplasms. Virchows Arch. 2001;438(3):271–9.PubMedCrossRefGoogle Scholar
  195. 195.
    Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol. 1998;22(6):673–82.PubMedCrossRefGoogle Scholar
  196. 196.
    Gu M, Antonescu CR, Guiter G, Huvos AG, Ladanyi M, Zakowski MF. Cytokeratin immunoreactivity in Ewing’s sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol. 2000;24(3):410–6.PubMedCrossRefGoogle Scholar
  197. 197.
    Creager A. Immunohisothemical, molecular, and cytogenetic analysis of bone and soft tissue tumors. In: Diagnostic musculoskeletal surgical pathology. 1st ed. New York: Elsevier; 2004. Accessed 19 May 2010.Google Scholar
  198. 198.
    Yasuda T, Perry KD, Nelson M, et al. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Hum Pathol. 2009;40(3):341–8.PubMedCrossRefGoogle Scholar
  199. 199.
    Bahrami A, Gown AM, Baird GS, Hicks MJ, Folpe AL. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. Mod Pathol. 2008;21(7):795–806.PubMedCrossRefGoogle Scholar
  200. 200.
    Weiss SW, Goldblum JR. Enzinger and Weiss’s soft tissue tumors. 5th ed. Philadelphia, PA, USA: Mosby Elsevier; 2008. p. 1257. Accessed 21 May 2010.Google Scholar
  201. 201.
    Carpentieri DF, Nichols K, Chou PM, Matthews M, Pawel B, Huff D. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors. Mod Pathol. 2002;15(10):1080–6.PubMedCrossRefGoogle Scholar
  202. 202.
    Megerian CA, Pilch BZ, Bhan AK, McKenna MJ. Differential expression of transthyretin in papillary tumors of the endolymphatic sac and choroid plexus. Laryngoscope. 1997;107(2):216–21.PubMedCrossRefGoogle Scholar
  203. 203.
    Devaney KO, Ferlito A, Rinaldo A. Endolymphatic sac tumor (low-grade papillary adenocarcinoma) of the temporal bone. Acta Otolaryngol. 2003;123(9):1022.PubMedCrossRefGoogle Scholar
  204. 204.
    Johnson TL, Zarbo RJ, Lloyd RV, Crissman JD. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing. Mod Pathol. 1988;1(3):216–23.PubMedGoogle Scholar
  205. 205.
    Li TJ, Yu SF, Gao Y, Wang EB. Clear cell odontogenic carcinoma: a clinicopathologic and immunocytochemical study of 5 cases. Arch Pathol Lab Med. 2001;125(12):1566–71.PubMedGoogle Scholar
  206. 206.
    Dong Q, Pan S, Sun LS, Li TJ. Orthokeratinized odontogenic cyst: a clinicopathologic study of 61 cases. Arch Pathol Lab Med. 2010;134(2):271–5.PubMedGoogle Scholar
  207. 207.
    Piattelli A, Fioroni M, Iezzi G, Rubini C, Dental School, University of Chieti, Italy. Calretinin expression in odontogenic cysts. J Endod. 2003;29(6):394.PubMedCrossRefGoogle Scholar
  208. 208.
    Ogden GR, Chisholm DM, Kiddie RA, et al. p53 Protein in odontogenic cysts: increased expression in some odontogenic keratocysts. J Clin Pathol. 1992;45:1007.PubMedCrossRefGoogle Scholar
  209. 209.
    Malcic A, Jukic S, Anic I, et al. Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst. J Oral Pathol Med. 2008;37(5):294.PubMedCrossRefGoogle Scholar
  210. 210.
    Altini M, Coleman H, Doglioni C, Favia G, Maiorano E. Calretinin expression in ameloblastomas. Histopathology. 2000;37(1):27–32.PubMedCrossRefGoogle Scholar
  211. 211.
    DeVilliers P, Liu H, Suggs C, et al. Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor. Am J Surg Pathol. 2008;32(2):256–60.PubMedCrossRefGoogle Scholar
  212. 212.
    Devilliers P, Liu H, Suggs C, et al. Calretinin in ameloblastoma of KCOT. Mod. Pathol. 2006 June Seg. 81.Google Scholar
  213. 213.
    Okamoto E, Kikuchi K, Miyazaki Y, et al. Significance of ­podoplanin expression in keratocystic odontogenic tumor. J Oral Pathol Med. 2010;39(1):110.Google Scholar
  214. 214.
    Piattelli A, Lezzi G, Fioroni M, Santinelli A, Rubini C. Ki-67 expression in dentigerous cysts, unicystic ameloblastomas, and ameloblastomas arising from dental cysts. J Endod. 2002;28(2):55–8.PubMedCrossRefGoogle Scholar
  215. 215.
    Osman M, Ferriera P. Ki 47 immunoreactivity in odontogenic keratocysts and orthokertinized jaw cysts. 2007. abstract:
  216. 216.
    Gurgel C, Ramos E, Azevedo R, Sarmento V, Carvalho A, Santos J. Expression of Ki-67, p53 and p63 proteins in keratocyst ­odontogenic tumours: an immunohistochemical study. Journal of molecular Histology 2008;39(3):311–316.Google Scholar
  217. 217.
    Eslami M, Eshghyar N, Tirgari F, Rezvani G. Ki-67 expression. Journal of Dentistry 2004;17(1).Google Scholar
  218. 218.
    Lo Muzio L, Santarelli A, Caltabiano R, et al. p63 Expression in odontogenic cysts. Int J Oral Maxillofac Surg. 2005;34(6):668–73.PubMedCrossRefGoogle Scholar
  219. 219.
    Coleman H, Altini M, Ali H, Doglioni C, Favia G, Maiorano E. Use of calretinin in the differential diagnosis of unicystic ameloblastomas. Histopathology. 2001;38(4):312–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory MedicineGeisinger Medical CenterDanvilleUSA

Personalised recommendations